En-bloc pelvic resection with concomitant rectosigmoid colectomy and immediate anastomosis as part of primary cytoreductive surgery for patients with advanced ovarian cancer
Özet
Objective: To assess the authors' experiences in en bloc pelvic resection with concomitant rectosigmoid colectomy and primary anastomosis as a part of primary cytoreductive surgery for patients with advanced ovarian cancer. Materials and Methods: A total of 22 patients with FIGO Stage IIB-IV epithelial ovarian cancer who underwent en bloc pelvic resection with anastomosis were retrospectively reviewed. Data analyses were carried out using SPSS 10.0 and descriptive statistics, Kaplan-Meier survival curves, and Log Rank (Mantel-Cox) test were used for statistical estimations. Results: Median age was 58.8 years. FIGO stage distribution of the patients was; one (4.5%) IIB, three (13.7%) IIC, three (13.7%) IIIA, six (27.3%) IIIB, and nine (40.9%) IIIC. Median peritoneal cancer index (PCI) was 8 (range 5-22) and optimal cytoreduction was achieved in 18 patients (81.8%) of whom 13 (59.1%) had no macroscopic residual disease (complete cytoreduction). There was no perioperative mortality. A total of nine complications occurred in seven (31.8%) patients. Anastomotic leakage was observed in one (4.5%) patient. There was no re-laparotomy. Mean follow-up time was 60 months. There were 15 (68.2%) recurrences of which 12 (80%) presented in extra-pelvic localizations. Mean disease-free survival (DFS) and overall survival (OVS) were estimated as 43.6 and 50.5 months, respectively. Patients with complete cytoreduction had a better DFS (p = 0.006) and OVS (p = 0.003) than those with incomplete cytoreduction. Conclusion: En bloc pelvic resection, as a part of surgical cytoreduction, seems to be a safe and effective procedure in many patients with advanced ovarian cancer if required. Despite relatively high general complication rate, anastomosis-related morbidity of this procedure is low as 0.8%. Nevertheless, surgical plan and perioperative care should be personalized according to medical and surgical conditions of the patient.
Anahtar Kelimeler
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Yildirim, Y. | |
| dc.contributor.author | Ertas, I.E. | |
| dc.contributor.author | Nayki, U. | |
| dc.contributor.author | Ulug, P. | |
| dc.contributor.author | Nayki, C. | |
| dc.contributor.author | Yilmaz, I. | |
| dc.contributor.author | Gultekin, E. | |
| dc.contributor.author | Dogan, A. | |
| dc.contributor.author | Aykas, A. | |
| dc.contributor.author | Ulug, S. | |
| dc.contributor.author | Ozdemir, A. | |
| dc.contributor.author | Solmaz, U. | |
| dc.date.accessioned | 2026-10-18T20:30:35.617871855Z | |
| dc.date.available | 2026-10-18T20:30:35.617871855Z | |
| dc.date.issued | 2014 | |
| dc.description.abstract | Objective: To assess the authors' experiences in en bloc pelvic resection with concomitant rectosigmoid colectomy and primary anastomosis as a part of primary cytoreductive surgery for patients with advanced ovarian cancer. Materials and Methods: A total of 22 patients with FIGO Stage IIB-IV epithelial ovarian cancer who underwent en bloc pelvic resection with anastomosis were retrospectively reviewed. Data analyses were carried out using SPSS 10.0 and descriptive statistics, Kaplan-Meier survival curves, and Log Rank (Mantel-Cox) test were used for statistical estimations. Results: Median age was 58.8 years. FIGO stage distribution of the patients was; one (4.5%) IIB, three (13.7%) IIC, three (13.7%) IIIA, six (27.3%) IIIB, and nine (40.9%) IIIC. Median peritoneal cancer index (PCI) was 8 (range 5-22) and optimal cytoreduction was achieved in 18 patients (81.8%) of whom 13 (59.1%) had no macroscopic residual disease (complete cytoreduction). There was no perioperative mortality. A total of nine complications occurred in seven (31.8%) patients. Anastomotic leakage was observed in one (4.5%) patient. There was no re-laparotomy. Mean follow-up time was 60 months. There were 15 (68.2%) recurrences of which 12 (80%) presented in extra-pelvic localizations. Mean disease-free survival (DFS) and overall survival (OVS) were estimated as 43.6 and 50.5 months, respectively. Patients with complete cytoreduction had a better DFS (p = 0.006) and OVS (p = 0.003) than those with incomplete cytoreduction. Conclusion: En bloc pelvic resection, as a part of surgical cytoreduction, seems to be a safe and effective procedure in many patients with advanced ovarian cancer if required. Despite relatively high general complication rate, anastomosis-related morbidity of this procedure is low as 0.8%. Nevertheless, surgical plan and perioperative care should be personalized according to medical and surgical conditions of the patient. | |
| dc.identifier.doi | 10.12892/ejgo24792014 | |
| dc.identifier.endpage | 407 | |
| dc.identifier.issn | 0392-2936 | |
| dc.identifier.issue | 4 | |
| dc.identifier.pmid | 25118481 | |
| dc.identifier.scopus | 2-s2.0-84905110271 | |
| dc.identifier.startpage | 400 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/ebyu/15746 | |
| dc.identifier.volume | 35 | |
| dc.identifier.wos | WOS:000339785000009 | |
| dc.language.iso | en | |
| dc.publisher | S.O.G. CANADA Inc. | |
| dc.relation.ispartof | European Journal of Gynaecological Oncology | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Cytoreductive surgery | |
| dc.subject | En-bloc pelvic resection | |
| dc.subject | Ovarian cancer | |
| dc.subject | Primary anastomosis | |
| dc.subject | Rectosigmoid colectomy | |
| dc.subject | Adenocarcinoma | |
| dc.subject | Adenocarcinoma, Clear Cell | |
| dc.subject | Adenocarcinoma, Mucinous | |
| dc.subject | Adult | |
| dc.subject | Aged | |
| dc.subject | Anastomosis, Surgical | |
| dc.subject | Carcinoma, Endometrioid | |
| dc.subject | Cohort Studies | |
| dc.subject | Colectomy | |
| dc.subject | Colon, Sigmoid | |
| dc.subject | Disease-Free Survival | |
| dc.subject | Female | |
| dc.subject | Humans | |
| dc.subject | Hysterectomy | |
| dc.subject | Kaplan-Meier Estimate | |
| dc.subject | Lymph Node Excision | |
| dc.subject | Middle Aged | |
| dc.subject | Neoplasms, Glandular and Epithelial | |
| dc.subject | Ovarian Neoplasms | |
| dc.subject | Ovariectomy | |
| dc.subject | Pelvic Exenteration | |
| dc.subject | Peritoneum | |
| dc.subject | Proctocolectomy, Restorative | |
| dc.subject | Rectum | |
| dc.subject | Retrospective Studies | |
| dc.title | En-bloc pelvic resection with concomitant rectosigmoid colectomy and immediate anastomosis as part of primary cytoreductive surgery for patients with advanced ovarian cancer | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| rdl.citation.scopus | 14 | |
| rdl.citation.wos | 11 | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | WOS | |
| rdl.wos.index | Science Citation Index Expanded (SCI-EXPANDED) |
